Canada markets closed

Cardiol Therapeutics Inc. (CT9.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
2.3700+0.1350 (+6.04%)
At close: 03:34PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
78.76
0
0
Operating Expenses
Research Development
15,802
18,962
10,870
10,603
3,530
Selling General and Administrative
15,050
22,374
27,873
10,088
10,447
Total Operating Expenses
30,852
41,336
38,744
20,690
14,128
Operating Income or Loss
-30,852
-41,336
-38,665
-20,690
-14,128
Interest Expense
-
-
-
0
0.621
Total Other Income/Expenses Net
670.587
9,168
6,921
-27.057
198.945
Income Before Tax
-28,006
-30,931
-31,638
-20,641
-13,684
Income from Continuing Operations
-28,006
-30,931
-31,638
-20,641
-13,684
Net Income
-28,006
-30,931
-31,638
-20,641
-13,684
Net Income available to common shareholders
-28,006
-30,931
-31,638
-20,641
-13,684
Basic EPS
-0.43
-0.49
-0.73
-0.69
-0.53
Diluted EPS
-0.43
-0.49
-0.73
-0.69
-0.53
Basic Average Shares
64,129
62,506
43,223
29,857
25,822
Diluted Average Shares
64,129
62,506
43,223
29,857
25,822